Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 106 articles:
HTML format



Single Articles


    January 2022
  1. COLUNGA-LOZANO LE, Kenji Nampo F, Agarwal A, Desai P, et al
    Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263240.
    PubMed     Abstract available


  2. HARVEY MJ, Zhong Y, Morris E, Beverage JN, et al
    Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma.
    PLoS One. 2022;17:e0261336.
    PubMed     Abstract available


  3. HUANG HH, Chen CM, Wang CY, Hsu WW, et al
    The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan.
    PLoS One. 2022;17:e0261871.
    PubMed     Abstract available


  4. HOWELL DA, McCaughan D, Smith AG, Patmore R, et al
    Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers-A qualitative study from the UK's Haematological Malignancy Research Network.
    PLoS One. 2022;17:e0263672.
    PubMed     Abstract available


  5. ZAREI GHOBADI M, Emamzadeh R
    Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
    PLoS One. 2022;17:e0262739.
    PubMed     Abstract available


  6. ASHOTI A, Limone F, van Kranenburg M, Alemany A, et al
    Considerations and practical implications of performing a phenotypic CRISPR/Cas survival screen.
    PLoS One. 2022;17:e0263262.
    PubMed     Abstract available


  7. NORTHGRAVES M, Allsup D, Cohen J, Huang C, et al
    A prospective registry-based cohort study of the diagnosis and management of acute leukaemia in pregnancy: Study protocol.
    PLoS One. 2022;17:e0263195.
    PubMed     Abstract available


  8. SAJIKI Y, Konnai S, Okagawa T, Maekawa N, et al
    Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.
    PLoS One. 2022;17:e0263660.
    PubMed     Abstract available


  9. SHELTON DN, Bhagavatula P, Sepulveda N, Beppu L, et al
    Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.
    PLoS One. 2022;17:e0265278.
    PubMed     Abstract available


  10. KUBO H, Imataki O, Kubo YH, Uemura M, et al
    c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia.
    PLoS One. 2022;17:e0263623.
    PubMed     Abstract available


  11. VAZQUEZ-CORNEJO E, Morales-Rios O, Hernandez-Pliego G, Cicero-Oneto C, et al
    Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico.
    PLoS One. 2022;17:e0265450.
    PubMed     Abstract available


  12. CESARO E, Falanga AP, Catapano R, Greco F, et al
    Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.
    PLoS One. 2022;17:e0266090.
    PubMed     Abstract available


  13. SZCZESNIAK PP, Heidelberger JB, Serve H, Beli P, et al
    VCP inhibition induces an unfolded protein response and apoptosis in human acute myeloid leukemia cells.
    PLoS One. 2022;17:e0266478.
    PubMed     Abstract available


  14. PARE A, Ellis A, Juette T
    Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008-2019).
    PLoS One. 2022;17:e0266621.
    PubMed     Abstract available


  15. PEARSON S, Whetton AD, Pierce A
    Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells.
    PLoS One. 2022;17:e0266298.
    PubMed     Abstract available


  16. MOPIN A, Lepretre F, Sebda S, Villenet C, et al
    Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.
    PLoS One. 2022;17:e0267508.
    PubMed     Abstract available


  17. MATOU-NASRI S, Najdi M, AlSaud NA, Alhaidan Y, et al
    Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling.
    PLoS One. 2022;17:e0267855.
    PubMed     Abstract available


  18. YAMAMOTO N, Kikuchi J, Furukawa Y, Shibayama N, et al
    Fast in-vitro screening of FLT3-ITD inhibitors using silkworm-baculovirus protein expression system.
    PLoS One. 2022;17:e0261699.
    PubMed     Abstract available


  19. HIRANO S, Udagawa O
    Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
    PLoS One. 2022;17:e0268835.
    PubMed     Abstract available


  20. HERNANDEZ VA, Carvajal-Moreno J, Wang X, Pietrzak M, et al
    Use of CRISPR/Cas9 with homology-directed repair to silence the human topoisomerase IIalpha intron-19 5' splice site: Generation of etoposide resistance in human leukemia K562 cells.
    PLoS One. 2022;17:e0265794.
    PubMed     Abstract available


  21. SIAMAKPOUR-REIHANI S, Cao F, Lyu J, Ren Y, et al
    Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.
    PLoS One. 2022;17:e0268963.
    PubMed     Abstract available


  22. GARNIASIH D, Susanah S, Sribudiani Y, Hilmanto D, et al
    The incidence and mortality of childhood acute lymphoblastic leukemia in Indonesia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269706.
    PubMed     Abstract available


  23. VIJAYVARGIYA P, Feri A, Mairey M, Rouillon C, et al
    Metagenomic shotgun sequencing of blood to identify bacteria and viruses in leukemic febrile neutropenia.
    PLoS One. 2022;17:e0269405.
    PubMed     Abstract available


  24. LIISBORG C, Skov V, Kjaer L, Hasselbalch HC, et al
    Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.
    PLoS One. 2022;17:e0269960.
    PubMed     Abstract available


    January 2021
  25. GANT VU, Junco JJ, Terrell M, Rashid R, et al
    Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.
    PLoS One. 2021;16:e0244863.
    PubMed     Abstract available


  26. MASHIMA K, Oh I, Fujiwara K, Izawa J, et al
    Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
    PLoS One. 2021;16:e0245232.
    PubMed     Abstract available


  27. JU HY, Lee JW, Cho HW, Hyun JK, et al
    DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.
    PLoS One. 2021;16:e0245667.
    PubMed     Abstract available


  28. SEITA A, Nakaoka H, Okura R, Wakamoto Y, et al
    Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug.
    PLoS One. 2021;16:e0236534.
    PubMed     Abstract available


  29. JALAL SD
    The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
    PLoS One. 2021;16:e0247491.
    PubMed     Abstract available


  30. MOSQUERA ORGUEIRA A, Peleteiro Raindo A, Cid Lopez M, Antelo Rodriguez B, et al
    Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
    PLoS One. 2021;16:e0247093.
    PubMed     Abstract available


  31. GHOBADI MZ, Emamzadeh R, Mozhgani SH
    Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia/lymphoma; the battle between oncogenes and anti-oncogenes.
    PLoS One. 2021;16:e0247713.
    PubMed     Abstract available


  32. UMAMAHESWARAN G, Kadambari D, Muthuvel SK, Kumar NAN, et al
    Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer.
    PLoS One. 2021;16:e0247989.
    PubMed     Abstract available


  33. CHANG Y, Guyatt GH, Teich T, Dawdy JL, et al
    Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
    PLoS One. 2021;16:e0249087.
    PubMed     Abstract available


  34. ELENS I, Deprez S, Billiet T, Sleurs C, et al
    Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors.
    PLoS One. 2021;16:e0250228.
    PubMed     Abstract available


  35. YOO KH, Kim HJ, Min YH, Hong DS, et al
    Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry.
    PLoS One. 2021;16:e0251011.
    PubMed     Abstract available


  36. YU W, Wang W, Yu X
    Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0253012.
    PubMed     Abstract available


  37. MOHSENI M, Kucharski C, K C RB, Nasrullah M, et al
    Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
    PLoS One. 2021;16:e0251719.
    PubMed     Abstract available


  38. KOVY P, Orfi Z, Bors A, Kozma A, et al
    Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
    PLoS One. 2021;16:e0253386.
    PubMed     Abstract available


  39. KIM SK, Goughnour PC, Lee EJ, Kim MH, et al
    Identification of drug combinations on the basis of machine learning to maximize anti-aging effects.
    PLoS One. 2021;16:e0246106.
    PubMed     Abstract available


  40. PONVILAWAN B, Kungwankiattichai S, Charoenngam N, Owattanapanich W, et al
    Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253896.
    PubMed     Abstract available


  41. CATHERINET C, Passaro D, Gachet S, Medyouf H, et al
    NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0254184.
    PubMed     Abstract available


  42. KARAMI K, Akbari M, Moradi MT, Soleymani B, et al
    Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques.
    PLoS One. 2021;16:e0254976.
    PubMed     Abstract available


  43. MOUSTAFA R, Albouni T, Aziz G
    The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients.
    PLoS One. 2021;16:e0253842.
    PubMed     Abstract available


  44. FAUZI YR, Nakahata S, Chilmi S, Ichikawa T, et al
    Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-kappaB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    PLoS One. 2021;16:e0256320.
    PubMed     Abstract available


  45. ZHANG W, Jang E
    Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis.
    PLoS One. 2021;16:e0256801.
    PubMed     Abstract available


  46. LONCAREVIC IF, Toepfer S, Hubold S, Klingner S, et al
    Ultra-precise quantification of mRNA targets across a broad dynamic range with nanoreactor beads.
    PLoS One. 2021;16:e0242529.
    PubMed     Abstract available


  47. VON BEEK C, Alriksson L, Palle J, Gustafson AM, et al
    Dynamin inhibition causes context-dependent cell death of leukemia and lymphoma cells.
    PLoS One. 2021;16:e0256708.
    PubMed     Abstract available


  48. GONZALEZ-RINCON J, Garcia-Vela JA, Gomez S, Fernandez-Cuevas B, et al
    Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
    PLoS One. 2021;16:e0257353.
    PubMed     Abstract available


  49. OCHIAI C, Miyauchi S, Kudo Y, Naruke Y, et al
    Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing.
    PLoS One. 2021;16:e0256588.
    PubMed     Abstract available


  50. ROSENTHAL SH, Gerasimova A, Ma C, Li HR, et al
    Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
    PLoS One. 2021;16:e0243683.
    PubMed     Abstract available


  51. MATSUO S, Nishinaka-Arai Y, Kazuki Y, Oshimura M, et al
    Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    PLoS One. 2021;16:e0247595.
    PubMed     Abstract available


  52. OLAYA-GALAN NN, Salas-Cardenas SP, Rodriguez-Sarmiento JL, Ibanez-Pinilla M, et al
    Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study.
    PLoS One. 2021;16:e0257492.
    PubMed     Abstract available


  53. LUONG A, Cerignoli F, Abassi Y, Heisterkamp N, et al
    Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
    PLoS One. 2021;16:e0258140.
    PubMed     Abstract available


  54. BAO F, Zhang L, Pei X, Lian C, et al
    MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
    PLoS One. 2021;16:e0256995.
    PubMed     Abstract available


  55. MOSQUERA ORGUEIRA A, Ferreiro Ferro R, Diaz Arias JA, Aliste Santos C, et al
    Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
    PLoS One. 2021;16:e0248886.
    PubMed     Abstract available


  56. PARKER C, Zomer E, Liew D, Ayton D, et al
    Characterising experiences with acute myeloid leukaemia using an Instagram content analysis.
    PLoS One. 2021;16:e0250641.
    PubMed     Abstract available


  57. ONO R, Masuya M, Inoue N, Shinmei M, et al
    Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    PLoS One. 2021;16:e0248425.
    PubMed     Abstract available


  58. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available


  59. MAHESHWARI VK, Slader C, Dani N, Gkitzia C, et al
    Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.
    PLoS One. 2021;16:e0259076.
    PubMed     Abstract available


  60. SEOMUN G, Lee J, Park J
    Exposure to extremely low-frequency magnetic fields and childhood cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251628.
    PubMed     Abstract available


  61. SADATO D, Hirama C, Kaiho-Soma A, Yamaguchi A, et al
    Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms.
    PLoS One. 2021;16:e0255257.
    PubMed     Abstract available


  62. NAGY-BALO Z, Kiss R, Demeter J, Bodor C, et al
    BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1.
    PLoS One. 2021;16:e0254853.
    PubMed     Abstract available


  63. HOFFMANN H, Baldow C, Zerjatke T, Gottschalk A, et al
    How to predict relapse in leukemia using time series data: A comparative in silico study.
    PLoS One. 2021;16:e0256585.
    PubMed     Abstract available


  64. CARDOSO BORGES F, Ramos A, Lourenco A, Gomes da Silva M, et al
    Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
    PLoS One. 2021;16:e0258423.
    PubMed     Abstract available


  65. BOLOURI H, Ries R, Pardo L, Hylkema T, et al
    A B-cell developmental gene regulatory network is activated in infant AML.
    PLoS One. 2021;16:e0259197.
    PubMed     Abstract available


  66. WAN PUTEH SE, Aizuddin AN, Tumian NR, Sathar J, et al
    Health-related quality of life using EQ-5D among chronic myeloid leukaemia patients in health centres in Klang Valley, Malaysia.
    PLoS One. 2021;16:e0256804.
    PubMed     Abstract available


  67. CHOI KH, Song JH, Kwak YK, Lee JH, et al
    Analysis of PET parameters predicting response to radiotherapy for myeloid sarcoma.
    PLoS One. 2021;16:e0261550.
    PubMed     Abstract available


  68. RODRIGUEZ OL, Sharp AJ, Watson CT
    Limitations of lymphoblastoid cell lines for establishing genetic reference datasets in the immunoglobulin loci.
    PLoS One. 2021;16:e0261374.
    PubMed     Abstract available


    January 2020
  69. MOGENSEN PR, Grell K, Schmiegelow K, Overgaard UM, et al
    Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231209.
    PubMed     Abstract available


  70. AGUILERA-DIAZ A, Vazquez I, Ariceta B, Manu A, et al
    Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
    PLoS One. 2020;15:e0227986.
    PubMed     Abstract available


  71. SOK P, Lupo PJ, Richard MA, Rabin KR, et al
    Utilization of archived neonatal dried blood spots for genome-wide genotyping.
    PLoS One. 2020;15:e0229352.
    PubMed     Abstract available


  72. WANG M, Zhang C
    Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
    PLoS One. 2020;15:e0232520.
    PubMed     Abstract available


  73. DRIEHUIS E, Oosterom N, Heil SG, Muller IB, et al
    Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231588.
    PubMed     Abstract available


  74. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available


  75. KOZLOVA V, Ledererova A, Ladungova A, Peschelova H, et al
    CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells.
    PLoS One. 2020;15:e0229170.
    PubMed     Abstract available


  76. ROBERTO G, Spini A, Bartolini C, Moscatelli V, et al
    Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.
    PLoS One. 2020;15:e0229973.
    PubMed     Abstract available


  77. CUESTA LM, Liron JP, Nieto Farias MV, Dolcini GL, et al
    Effect of bovine leukemia virus (BLV) infection on bovine mammary epithelial cells RNA-seq transcriptome profile.
    PLoS One. 2020;15:e0234939.
    PubMed     Abstract available


  78. MAALAND AF, Saidi A, Torgue J, Heyerdahl H, et al
    Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003.
    PLoS One. 2020;15:e0230526.
    PubMed     Abstract available


  79. SCHONHERZ AA, Bodker JS, Schmitz A, Brondum RF, et al
    Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact.
    PLoS One. 2020;15:e0229593.
    PubMed     Abstract available


  80. RODRIGUES JCG, Souza TP, Pastana LF, Ribeiro Dos Santos AM, et al
    Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil.
    PLoS One. 2020;15:e0231651.
    PubMed     Abstract available



  81. Correction: Effect of bovine leukemia virus (BLV) infection on bovine mammary epithelial cells RNA-seq transcriptome profile.
    PLoS One. 2020;15:e0236912.
    PubMed     Abstract available


  82. LI J, Ran Q, Xu B, Luo X, et al
    Role of CD25 expression on prognosis of acute myeloid leukemia: A literature review and meta-analysis.
    PLoS One. 2020;15:e0236124.
    PubMed     Abstract available


  83. LAVAU CP, Aumann WK, Sze SK, Gupta V, et al
    The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
    PLoS One. 2020;15:e0232036.
    PubMed     Abstract available


  84. PRIEST ND, Dauer LT, Hoel DG
    Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.
    PLoS One. 2020;15:e0232597.
    PubMed     Abstract available


  85. YOO KH, Cho J, Han B, Kim SH, et al
    Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults.
    PLoS One. 2020;15:e0235503.
    PubMed     Abstract available



  86. Retraction: S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells.
    PLoS One. 2020;15:e0237489.
    PubMed    


  87. DRIEHUIS E, Oosterom N, Heil SG, Muller IB, et al
    Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0237488.
    PubMed     Abstract available


  88. BRIX N, Rosthoj S, Glerup M, Hasle H, et al
    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children.
    PLoS One. 2020;15:e0237530.
    PubMed     Abstract available


  89. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available


  90. GRAYSON JM, Perez MD, Blevins R, Coe BN, et al
    Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity.
    PLoS One. 2020;15:e0234778.
    PubMed     Abstract available


  91. JOHANSSON KA, Okland JM, Skaftun EK, Bukhman G, et al
    Estimating Health Adjusted Age at Death (HAAD).
    PLoS One. 2020;15:e0235955.
    PubMed     Abstract available


  92. BORIES P, Prade N, Lagarde S, Cabarrou B, et al
    Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
    PLoS One. 2020;15:e0238795.
    PubMed     Abstract available


  93. DELARMELINA E, Buzelin MA, Souza BS, Souto FM, et al
    High positivity values for bovine leukemia virus in human breast cancer cases from Minas Gerais, Brazil.
    PLoS One. 2020;15:e0239745.
    PubMed     Abstract available


  94. LEWIS TR, Smith J, Griffin K, Aguiar S, et al
    NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation.
    PLoS One. 2020;15:e0236839.
    PubMed     Abstract available


  95. NAGEL S, Pommerenke C, Meyer C, MacLeod RAF, et al
    Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia.
    PLoS One. 2020;15:e0240120.
    PubMed     Abstract available


  96. RATTANATHAMMETHEE T, Tuitemwong P, Thiennimitr P, Sarichai P, et al
    Gut microbiota profiles of treatment-naive adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
    PLoS One. 2020;15:e0236460.
    PubMed     Abstract available


  97. LUO L, Kang H, Li X, Ness SA, et al
    Two-step mixed model approach to analyzing differential alternative RNA splicing.
    PLoS One. 2020;15:e0232646.
    PubMed     Abstract available


  98. TURK S, Turk C, Akbar MW, Kucukkaraduman B, et al
    Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide.
    PLoS One. 2020;15:e0242497.
    PubMed     Abstract available


  99. SZAKACS Z, Hegyi PJ, Farkas N, Hegyi P, et al
    Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A systematic review.
    PLoS One. 2020;15:e0243045.
    PubMed     Abstract available


  100. INHESTERN L, Peikert ML, Krauth KA, Escherich G, et al
    Parents' perception of their children's process of reintegration after childhood cancer treatment.
    PLoS One. 2020;15:e0239967.
    PubMed     Abstract available


  101. ZHANG W, Kuang P, Liu T
    Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis.
    PLoS One. 2020;15:e0243657.
    PubMed     Abstract available


  102. BURNS JE, Reyes Perez D, Li Y, Gomez Garcia W, et al
    Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican Republic.
    PLoS One. 2020;15:e0243795.
    PubMed     Abstract available


  103. SAHAJPAL NS, Mondal AK, Ananth S, Njau A, et al
    Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.
    PLoS One. 2020;15:e0240976.
    PubMed     Abstract available


  104. YUAN B, El Dana F, Ly S, Yan Y, et al
    Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-beta-p38-ALDH2 pathway.
    PLoS One. 2020;15:e0242809.
    PubMed     Abstract available


    January 2019
  105. NAGEL S, Scherr M, MacLeod RAF, Pommerenke C, et al
    NKL homeobox gene activities in normal and malignant myeloid cells.
    PLoS One. 2019;14:e0226212.
    PubMed     Abstract available


  106. ALI EA, Kalli M, Wan D, Nakamura R, et al
    Characterization of human FcepsilonRIalpha chain expression and gene copy number in humanized rat basophilic leukaemia (RBL) reporter cell lines.
    PLoS One. 2019;14:e0221034.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: